[The role of cardiac insufficiency in septic shock. Physiopathologic and therapeutic considerations].
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004298:Dopamine / Q000627:therapeutic use; D004731:Endotoxins / Q000494:pharmacology; D006321:Heart / Q000503:physiopathology; D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000627:therapeutic use; D010101:Oxygen Consumption / Q000187:drug effects; D010138:Pacemaker, Artificial; D011654:Pulmonary Edema / Q000503:physiopathology; D012772:Shock, Septic / Q000150:complications* / Q000378:metabolism / Q000628:therapy; D014655:Vascular Resistance / Q000187:drug effects
D004731:Endotoxins; D007545:Isoproterenol; D004298:Dopamine; D009638:Norepinephrine
La place de l'insuffisance cardiaque dans le choc septique. Considérations physiopathologiques et thérapeutiques